KeyBiosciences

Showing 1 posts of 1 posts found.

Lilly bolsters diabetes assets with $55m KeyBioscience deal

June 9, 2017
Medical Communications, Sales and Marketing Eli Lilly, KeyBiosciences

Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …

The Gateway to Local Adoption Series

Latest content